SynthesisClinical drug investigation2018

Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review.

Jie Fu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.